Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections

Journal of the American College of Cardiology

Volumn 49, Issue 18, 2007, Pages 1851-1859

  Sohail, Muhammad R ^a   Uslan, Daniel Z ^a   Khan, Akbar H ^a   Friedman, Paul A ^a   Hayes, David L ^a   Wilson, Walter R ^a   Steckelberg, James M ^a   Stoner, Sarah ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LEAD;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL FEATURE; CLINICAL STUDY; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; COLITIS; DEFIBRILLATOR; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DEVICE INFECTION; DEVICE REMOVAL; DIARRHEA; ENDOCARDITIS; FEMALE; FOLLOW UP; GENERATOR; HEALTH CARE FACILITY; HOSPITAL DISCHARGE; HUMAN; IMPLANT; INFORMATION PROCESSING; INSTITUTIONAL REVIEW; MAJOR CLINICAL STUDY; MALE; METAL EXTRACTION; NEPHROTOXICITY; NEUTROPENIA; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE; THRUSH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL INFECTIONS; DEBRIDEMENT; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ENDOCARDITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 34247464146     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.01.072     Document Type: Article

References (53)

1. Uslan D.Z., and Baddour L.M. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis 19 (2006) 345-348
2. Goldberger Z., and Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 295 (2006) 809-818
3. Cabell C.H., Heidenreich P.A., Chu V.H., et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 147 (2004) 582-586
4. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular cardiovascular device-related infections. Circulation 108 (2003) 2015-2031
5. Mela T., McGovern B.A., Garan H., et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 88 (2001) 750-753
6. Frame R., Brodman R.F., Furman S., Andrews C.A., and Gross J.N. Surgical removal of infected transvenous pacemaker leads. Pacing Clin Electrophysiol 16 (1993) 2343-2348
7. Lai K.K., and Fontecchio S.A. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis 27 (1998) 265-269
8. Smith P.N., Vidaillet H.J., Hayes J.J., et al., Endotak Lead Clinical Investigators. Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented?. Pacing Clin Electrophysiol 21 (1998) 42-55
9. Hill P.E. Complications of permanent transvenous cardiac pacing: a 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin Electrophysiol 10 (1987) 564-570
10. Chu V.H., Crosslin D.R., Friedman J.Y., et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med 118 (2005) 1416
11. Cacoub P., Leprince P., Nataf P., et al. Pacemaker infective endocarditis. Am J Cardiol 82 (1998) 480-484
12. Klug D., Lacroix D., Savoye C., et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 95 (1997) 2098-2107
13. Darouiche R.O. Treatment of infections associated with surgical implants. N Engl J Med 350 (2004) 1422-1429
14. Ferguson Jr. T.B., Ferguson C.L., Crites K., and Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg 111 (1996) 742-751 discussion 751-2
15. Arber N., Pras E., Copperman Y., et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine 73 (1994) 299-305
16. Lee M.E., Chaux A., and Matloff J.M. Avulsion of a tricuspid valve leaflet during traction on an infected, entrapped endocardial pacemaker electrode. The role of electrode design. J Thorac Cardiovasc Surg 74 (1977) 433-435
17. Chamis A.L., Peterson G.E., Cabell C.H., et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 104 (2001) 1029-1033
18. Uslan D.Z., Sohail M.R., Friedman P.A., et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 43 (2006) 731-736
19. Chua J.D., Wilkoff B.L., Lee I., Juratli N., Longworth D.L., and Gordon S.M. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 133 (2000) 604-608
20. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
21. Sanfilippo A.J., Picard M.H., Newell J.B., et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 18 (1991) 1191-1199
22. del Rio A., Anguera I., Miro J.M., et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 124 (2003) 1451-1459
23. Victor F., De Place C., Camus C., et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 81 (1999) 82-87
24. Orsinelli D.A., and Pearson A.C. Detection of prosthetic valve strands by transesophageal echocardiography: clinical significance in patients with suspected cardiac source of embolism. J Am Coll Cardiol 26 (1995) 1713-1718
25. Klug D., Wallet F., Lacroix D., et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 90 (2004) 882-886
26. Turkisher V., Priel I., and Dan M. Successful management of an infected implantable cardioverter defibrillator with oral antibiotics and without removal of the device. Pacing Clin Electrophysiol 20 (1997) 2268-2270
27. Lee J.H., Geha A.S., Rattehalli N.M., et al. Salvage of infected ICDs: management without removal. Pacing Clin Electrophysiol 19 (1996) 437-442
28. Hurst L.N., Evans H.B., Windle B., and Klein G.J. The salvage of infected cardiac pacemaker pockets using a closed irrigation system. Pacing Clin Electrophysiol 9 (1986) 785-792
29. O'Nunain S., Perez I., Roelke M., et al. The treatment of patients with infected implantable cardioverter-defibrillator systems. J Thorac Cardiovasc Surg 113 (1997) 121-129
30. Lewis A.B., Hayes D.L., Holmes Jr. D.R., Vlietstra R.E., Pluth J.R., and Osborn M.J. Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg 89 (1985) 758-763
31. Bracke F.A., Meijer A., and van Gelder L.M. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data?. Heart 85 (2001) 254-259
32. Rundstrom H., Kennergren C., Andersson R., Alestig K., and Hogevik H. Pacemaker endocarditis during 18 years in Goteborg. Scand J Infect Dis 36 (2004) 674-679
33. Camus C., Leport C., Raffi F., Michelet C., Cartier F., and Vilde J.L. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis 17 (1993) 46-55
34. Vogt P.R., Sagdic K., Lachat M., Candinas R., von Segesser L.K., and Turina M.I. Surgical management of infected permanent transvenous pacemaker systems: ten year experience. J Card Surg 11 (1996) 180-186
35. Molina J.E. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices. Ann Thorac Surg 63 (1997) 504-509
36. Love C.J., Wilkoff B.L., Byrd C.L., et al., North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. Pacing Clin Electrophysiol 23 (2000) 544-551
37. Klug D., Wallet F., Kacet S., and Courcol R.J. Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms. Am Heart J 149 (2005) 322-328
38. Harjula A., Jarvinen A., Virtanen K.S., and Mattila S. Pacemaker infections-treatment with total or partial pacemaker system removal. Thorac Cardiovasc 33 (1985) 218-220
39. Parry G., Goudevenos J., Jameson S., Adams P.C., and Gold R.G. Complications associated with retained pacemaker leads. Pacing Clin Electrophysiol 14 (1991) 1251-1257
40. Rettig G., Doenecke P., Sen S., Volkmer I., and Bette L. Complications with retained transvenous pacemaker electrodes. Am Heart J 98 (1979) 587-594
41. Wilhelm M.J., Schmid C., Hammel D., et al. Cardiac pacemaker infection: surgical management with and without extracorporeal circulation. Ann Thorac Surg 64 (1997) 1707-1712
42. Klug D., Balde M., Pavin D., et al. Prospective Evaluation of Pacemaker Lead Endocarditis (PEOPLE study): 12 months incidence and risk factors of pacemaker-related infections. Eur Heart J 25 Suppl (2004) 27 (abstr)
43. Sohail MR, Khan AH, Freidman PA, et al. Electrophysiologic cardiac device infections: risk factor analysis using a case-control study. Presented at: Infectious Diseases Society of America (IDSA), San Francisco, CA: 2005, abstract no. 343.
44. Wilkoff B.L., Byrd C.L., Love C.J., et al. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol 33 (1999) 1671-1676
45. Voet J.G., Vandekerckhove Y.R., Muyldermans L.L., Missault L.H., and Matthys L.J. Pacemaker lead infection: report of three cases and review of the literature. Heart 81 (1999) 88-91
46. Dumont E., Camus C., Victor F., et al. Suspected pacemaker or defibrillator transvenous lead infection. Prospective assessment of a TEE-guided therapeutic strategy. Eur Heart J 24 (2003) 1779-1787
47. Meier-Ewert H.K., Gray M.E., and John R.M. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am Heart J 146 (2003) 339-344
48. Nguyen K.T., Neese P., and Kessler D.J. Successful laser-assisted percutaneous extraction of four pacemaker leads associated with large vegetations. Pacing Clin Electrophysiol 23 (2000) 1260-1262
49. Ruttmann E., Hangler H.B., Kilo J., et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol 29 (2006) 231-236
50. Kennelly B.M., and Piller L.W. Management of infected transvenous permanent pacemakers. Br Heart J 36 (1974) 1133-1140
51. Mansour K.A., Kauten J.R., and Hatcher Jr. C.R. Management of the infected pacemaker: explantation, sterilization, and reimplantation. Ann Thorac Surg 40 (1985) 617-619
52. Klug D., Balde M., Pavin D., et al. Prospective evaluation of pacemaker lead endocarditis: 6 months preliminary results. Eur Heart J 24 (2003) 28 (abstr)
53. Bohm A., Banyai F., Preda I., and Zamolyi K. The treatment of septicemia in pacemaker patients. Pacing Clin Electrophysiol 19 (1996) 1105-1111